derived_fields listlengths 1 1 | document_number stringclasses 4
values | effective_period stringclasses 4
values | extension_number stringclasses 4
values | federal_register_citation stringclasses 4
values | flexibility_extended_through stringdate 2023-11-11 00:00:00 2026-12-31 00:00:00 | id stringclasses 4
values | limited_extension stringclasses 1
value | publication_date stringclasses 4
values | source stringclasses 4
values | source_quote stringclasses 4
values | url stringclasses 4
values | verified_fields listlengths 6 6 | expiry_date_replaced stringclasses 3
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
[
"extension_number"
] | 2023-09936 | This rule is effective May 11, 2023, through November 11, 2024. | Extension 1: First Temporary Rule | 88 FR 30037 | November 11, 2023 | extension-1-first-temporary-rule | through November 11, 2024, but only with respect to patients with whom the prescribing practitioner has a telemedicine relationship established via COVID-19 telemedicine prescribing flexibilities on or before November 11, 2023 | 05/10/2023 | https://www.federalregister.gov/documents/2023/05/10/2023-09936/temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled | A Rule by the Drug Enforcement Administration and the Health and Human Services Department on 05/10/2023 Published Document: 2023-09936 (88 FR 30037) | https://referencesource.org/dea-telemedicine-prescribing-flexibility-extensions/extension-1-first-temporary-rule/ | [
"document_number",
"effective_period",
"federal_register_citation",
"flexibility_extended_through",
"limited_extension",
"publication_date"
] | null |
[
"extension_number"
] | 2023-22406 | As of November 11, 2023, the end of the effective period for the temporary rule published at 88 FR 30037 on May 10, 2023, is extended from November 11, 2024, to December 31, 2024. This rule is effective November 11, 2023. | Extension 2: Second Temporary Rule | 88 FR 69879 | December 31, 2024 | extension-2-second-temporary-rule | null | 10/10/2023 | https://www.federalregister.gov/documents/2023/10/10/2023-22406/second-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled | A Rule by the Drug Enforcement Administration and the Health and Human Services Department on 10/10/2023 Published Document: 2023-22406 (88 FR 69879) | https://referencesource.org/dea-telemedicine-prescribing-flexibility-extensions/extension-2-second-temporary-rule/ | [
"document_number",
"effective_period",
"expiry_date_replaced",
"federal_register_citation",
"flexibility_extended_through",
"publication_date"
] | November 11, 2023 |
[
"extension_number"
] | 2024-27018 | This rule is effective January 1, 2025, through December 31, 2025. | Extension 3: Third Temporary Rule | 89 FR 91253 | December 31, 2025 | extension-3-third-temporary-rule | null | 11/19/2024 | https://www.federalregister.gov/d/2024-27018 | A Rule by the Drug Enforcement Administration and the Health and Human Services Department on 11/19/2024 Published Document: 2024-27018 (89 FR 91253) | https://referencesource.org/dea-telemedicine-prescribing-flexibility-extensions/extension-3-third-temporary-rule/ | [
"document_number",
"effective_period",
"expiry_date_replaced",
"federal_register_citation",
"flexibility_extended_through",
"publication_date"
] | December 31, 2024 |
[
"extension_number"
] | 2025-24123 | This rule is effective January 1, 2026 through December 31, 2026. | Extension 4: Fourth Temporary Rule | 90 FR 61301 | December 31, 2026 | extension-4-fourth-temporary-rule | null | 12/31/2025 | https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled | A Rule by the Drug Enforcement Administration and the Health and Human Services Department on 12/31/2025 Published Document: 2025-24123 (90 FR 61301) | https://referencesource.org/dea-telemedicine-prescribing-flexibility-extensions/extension-4-fourth-temporary-rule/ | [
"document_number",
"effective_period",
"expiry_date_replaced",
"federal_register_citation",
"flexibility_extended_through",
"publication_date"
] | December 31, 2025 |
DEA telemedicine controlled-substance prescribing flexibility -- extension history
Canonical, always-current version: https://referencesource.org/dea-telemedicine-prescribing-flexibility-extensions/ Machine-readable: https://referencesource.org/dea-telemedicine-prescribing-flexibility-extensions/data.json — this mirror is a point-in-time copy.
- Last verified: 2026-10-30
- Stale after: 2026-10-30 (past this date, prefer the canonical copy — it re-verifies on a cadence this snapshot does not)
- Records: 4
Under the Ryan Haight Act a practitioner may normally prescribe a controlled substance only after at least one in-person evaluation of that patient. In March 2020 the DEA suspended that requirement for the COVID-19 public health emergency, and since the emergency ended on 11 May 2023 the suspension has been kept alive only by a chain of temporary rules -- four of them so far, each amending 21 CFR 1307.41 and 42 CFR 12.1 to push one expiry date to a later one, with a permanent 'special registration' rule still only a proposal. This asset is one record per temporary rule, carrying the rule's own DATES statement, the date it extended the flexibility to, and the earlier expiry date it replaced, each quoted from that rule's own Federal Register document. Two things make the history worth assembling. First, the dates are easy to get wrong: the First Temporary Rule is dated 'effective May 11, 2023, through November 11, 2024', but the general flexibility under it actually ran only to 11 November 2023 -- the extra year applied solely to practitioner-patient relationships already established by that date. Second, each rule is a standalone document that supersedes the last without amending it, so a reader who lands on any one of the first three sees a deadline that has already passed with nothing on the page to say so. The newest rule's preamble does narrate the earlier three in prose, which is where a careful reader can reconstruct the sequence; this asset states it as four dated, separately-sourced records instead.
Provenance — what every record carries
Every record carries source (the URL the value was read from) and
source_quote (a verbatim quote from that page stating it). A value you
cannot check against its page is indistinguishable from an invented one;
these can all be checked. Each record is also individually addressable on
the canonical site at its url.
Licence position
Facts extracted from the Federal Register, a US government work not subject to copyright. Each record quotes a short verbatim span of the rule it describes and links back to that document on federalregister.gov.
Facts are not copyrightable; what this dataset takes from each source is a fact plus a short attributed quote linking back to the page that states it.
Sources
- https://www.federalregister.gov/documents/2023/05/10/2023-09936/temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled
- https://www.federalregister.gov/documents/2023/10/10/2023-22406/second-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled
- https://www.federalregister.gov/d/2024-27018
- https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled
Fields
See any record in data/records.jsonl — field names are self-describing,
and the canonical page for each record renders them with labels:
https://referencesource.org/dea-telemedicine-prescribing-flexibility-extensions/
- Downloads last month
- 146